Endoscopic Technology for the Treatment of GERD.

Results of a clinical trial reported:

• 90% of patients reported no or mild regurgitation 6 months post-procedure.*
• >70% reduction in overall symptoms.*
• 75% reduction in use of multiple medications or daily proton pump inhibitors.*

• Find out more information about ELGP.
• Find a physician near you that performs ELGP using the Bard EndoCinch System.
• Advantages over the alternative treatments for GERD.
• Frequently Asked Questions (FAQ's).

*Data on file.

EndoCinch Home :: Patient Center :: Doctor Center :: Press Releases
About EndoCinch/CR Bard :: Clinical Support :: Contact Us :: Site Map :: Privacy Policy :: Terms of Use
1-800-556-6275

© 2005 C.R. Bard. All rights reserved. Davol Inc. is a subsidiary of C.R. Bard, Inc. or an affiliate.
* Bard and Davol are registered trademarks and EndoCinch is a trademark of C.R. Bard, Inc. or an affiliate.

This site is not intended as a substitute for professional medical care. Only your physician can diagnose and appropriately treat your symptoms.

Please consult product labeling and instructions for use for all indications, contraindications, warnings, precautions and directions for use.